Testing Lung Cancer Cells for Drug Sensitivity
Author Information
Author(s): J. Carmichael, J.B. Mitchell, W.G. DeGraff, J. Gamson, A.F. Gazdar, B.E. Johnson, E. Glatstein, J.D. Minna
Primary Institution: National Cancer Institute
Hypothesis
Do lung cancer cell lines in vitro have a similar spectrum of chemosensitivity and resistance, and can differences be detected using a simple growth assay?
Conclusion
The study found that untreated small cell lung cancer cell lines were the most sensitive to several chemotherapy drugs compared to treated small cell and non-small cell lung cancer lines.
Supporting Evidence
- Untreated small cell lung cancer cell lines were the most chemosensitive to adriamycin, melphalan, vincristine, and VP16.
- Untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin.
- Treated SCLC was more sensitive to vincristine compared to non-SCLC lines.
- No significant differences were observed for vinblastine between lung cancer types.
Takeaway
Scientists tested 30 lung cancer cell lines to see how sensitive they are to different cancer drugs, finding that untreated small cell lung cancer cells respond better to treatment than others.
Methodology
The study used a semi-automated MTT assay to test the chemosensitivity of 30 human lung cancer cell lines derived from different patient treatment statuses.
Limitations
Variability in IC50 values was observed between experiments, which may affect the reproducibility of results.
Participant Demographics
The cell lines were derived from patients with untreated small cell lung cancer, relapsed small cell lung cancer, and non-small cell lung cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website